Skip to main content
ALLURION TECHNOLOGIES, INC. logo

ALLURION TECHNOLOGIES, INC. — Investor Relations & Filings

Ticker · ALUR ISIN · US02008G1022 US Human health and social work activities
Filings indexed 303 across all filing types
Latest filing 2025-01-14 Regulatory Filings
Country US United States of America
Listing US ALUR

About ALLURION TECHNOLOGIES, INC.

https://www.allurion.com/en

Allurion Technologies, Inc. is a company focused on ending obesity through its comprehensive weight-loss platform, the Allurion Program. The program's core component is a procedure-less, swallowable gastric balloon that is placed during an outpatient visit and passes naturally after approximately four months. This device is integrated into a full-stack solution that includes a digital ecosystem for real-time progress tracking via connected devices, an AI-powered coaching assistant, and personalized support from a multidisciplinary team of healthcare professionals. The platform is designed to promote sustainable, metabolically healthy weight loss by combining appetite regulation with behavioral change support. It can function as a standalone treatment or in combination with other therapies, including the company's AI-native compounded GLP-1 program.

Recent filings

Filing Released Lang Actions
RW
Regulatory Filings Classification · 100% confidence The document is a letter from Allurion Technologies, Inc. to the SEC requesting withdrawal of a registration statement on Form S-1. It references Rule 477 under the Securities Act and discusses the withdrawal of a registration statement that was filed but not declared effective. The document is a formal regulatory communication related to a filing withdrawal, not a financial report, earnings release, or other report type. It does not contain financial data or detailed report content but is a regulatory filing related to registration withdrawal. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is a formal letter, not a report or announcement of a report publication, so RPA is not appropriate.
2025-01-14 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the securities being offered, terms of the offering, and related legal and financial disclosures. This is a capital raising filing, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual registration statement document. Therefore, it fits the category of Capital/Financing Update filings.
2025-01-13 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-01-11 English
424B3
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed by Allurion Technologies, Inc. It includes detailed disclosures about amendments to material definitive agreements, financial condition updates, and other significant corporate events. The text references a Registration Statement on Form S-1 and includes audited and unaudited financial statements and MD&A incorporated by reference, but these are exhibits to the 8-K, not the report itself. The document is not an Annual Report (10-K) or Interim Report (IR) but a current report disclosing material events and amendments. It also includes a prospectus supplement and references to financing agreements and stock split amendments. The primary nature of the document is a regulatory filing reporting material corporate events and financial updates outside of periodic reports. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-01-08 English
424B3
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Allurion Technologies, Inc. It includes detailed disclosures about amendments to note purchase agreements, revenue interest financing agreements, and an omnibus amendment affecting the company's financing and governance. It also references audited and unaudited financial statements and management's discussion and analysis (MD&A) filed as exhibits, but these are incorporated by reference rather than presented in full within the document. The document also includes a press release about clinical trial results. The filing is primarily an update on material definitive agreements and financial condition, typical of a Current Report on Form 8-K. It is not a full annual or quarterly report, nor is it a proxy, earnings release, or other specific report type. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other categories.
2025-01-08 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Allurion Technologies, Inc. It includes disclosures about an amendment to a note purchase agreement and revenue interest financing agreements, details about a reverse stock split, and references to financial statements and management discussion and analysis (MD&A) filed as exhibits. The document also mentions a press release about clinical trial results. The content primarily focuses on material definitive agreements, financial condition updates, and regulatory disclosures rather than presenting a full annual or quarterly report. The Form 8-K is a regulatory filing used to announce significant events and updates to investors and the SEC. Given the nature of the content and the form type, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific report types.
2025-01-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.